Results 31 to 40 of about 2,534,664 (269)

Respite Partnership Collaborative (RPC) Innovation Project Evaluation: Report 2 [PDF]

open access: yes, 2015
The Mental Health Services Act (MHSA)—funded by Proposition 63—supports five unique components: (1) Community Services and Supports, (2) Prevention and Early Intervention, (3) Workforce Education and Training, (4) Capital Facilities and Technology, and ...
Anita Poon   +5 more
core  

Unheard and Under‐Supported: Health‐Related Quality of Life in Children, Adolescents, and Young Adults With Sickle Cell Disease

open access: yesPediatric Blood &Cancer, EarlyView.
Abstract Background Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy affecting millions of individuals worldwide. The clinical expression and psychosocial burden of SCD vary widely across geographical, cultural, and healthcare system contexts, underscoring the need for setting‐specific approaches to assessment.
Desiré Fantasia   +7 more
wiley   +1 more source

Enhancing Future Health Equity Plans: Insights from an Evaluation of Public Health Equity Resources in Oregon

open access: yesHealth Equity
Health Equity Action Plans (HEAPs) are a recent strategy employed across health and human services to promote health equity. To inform the development of future HEAPs, as well as to build upon previous initiatives, we evaluated 52 health equity plans and
Alyssa Pinoliar   +3 more
doaj   +1 more source

Respite Partnership Collaborative (RPC) Innovation Project Evaluation: Final Report [PDF]

open access: yes, 2016
The Mental Health Services Act (MHSA)—funded by Proposition 63—supports five unique components: (1) Community Services and Supports, (2) Prevention and Early Intervention, (3) Workforce Education and Training, (4) Capital Facilities and Technology, and ...
Anita Poon   +4 more
core  

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

The burden of infant group B streptococcal infections in Ontario: Analysis of administrative data to estimate the potential benefits of new vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Group B streptococcus (GBS) is a leading bacterial cause of neonatal sepsis and meningitis in many countries as well as an important cause of disease in pregnant women. Currently, serotype-specific conjugate vaccines are being developed.
James Hartley   +3 more
doaj   +1 more source

The local evaluation of Halton's Healthy Living programme annual reach report, August 2004 - July 2005 [PDF]

open access: yes, 2005
This project report discusses an evaluation of the services of Halton's Healthy Living Centre, which aims to promote good health, reduce health inequalities, and improve the health of the most disadvantaged in ...
Alford, Simon   +2 more
core  

Reducing avoidable inequalities in health: a new criterion for setting health care capitation payments [PDF]

open access: yes, 2002
Traditionally, most health care systems which pretend to any sort of rationality and cost control have sought to allocate their limited funds in order to secure equal opportunity of access for equal need.
Acheson   +30 more
core   +2 more sources

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy